Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10813	Companies
234250	Keywords
163043	Articles
125263	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 6 months ago

Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101
Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101. L'objectif est de co-développer et commercialiser le traitement en Chine

Biophytis Négociation Exclusive BIO101 Co-développement Société Pharmaceutique Chinoise
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 6 months ago

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101
Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market

Biophytis Exclusive Negotiations Chinese Pharmaceutical Company BIO101 License Viral Respiratory Infections
BRIEF

published on 01/08/2025 at 07:05, 1 year 7 months ago

Biophytis obtient des financements pour son programme d'obésité

Investissement Biophytis Refinancement BIO101 Obésité
BRIEF

published on 01/08/2025 at 07:05, 1 year 7 months ago

Biophytis Secures €8.6 Million for Obesity Program

Clinical Development Debt Conversion Obesity Program Biophytis Financing New Investors
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 7 months ago

Biophytis annonce un nouvel apport en cash et une conversion de dettes pouvant atteindre 8,6 M€ pour financer son programme dans l’obésité
Biophytis annonce un nouvel apport en cash de 2,5 M€ et une conversion de dettes jusqu'à 6,1 M€ pour financer son programme dans l'obésité. Opération de refinancement de 8,6 M€ pour consolider sa structure financière et lancer l'étude de phase 2 OBA aux États-Unis

Biophytis Financement Développement Clinique Opération Financière Obésité
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 7 months ago

Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development

Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution
BRIEF

published on 01/06/2025 at 08:35, 1 year 7 months ago

Biophytis suspend temporairement la cotation de ses actions pour un refinancement

Biophytis Biotechnologie Euronext Growth Refinancement Suspension De Cotation
BRIEF

published on 01/06/2025 at 08:35, 1 year 7 months ago

Biophytis Temporarily Suspends Trading of Shares Before Refinancing

Biophytis Biotechnology Refinancing Age-related Diseases Trading Suspension
REGULATED PRESS RELEASE

published on 01/06/2025 at 08:30, 1 year 7 months ago

Biophytis annonce la suspension temporaire de la cotation de ses actions et de ses BSA avant la conclusion d'une opération de refinancement
Biophytis annonce la suspension temporaire de la cotation de ses actions et de ses BSA avant la conclusion d'une opération de refinancement. Pour plus d'informations, visitez www.biophytis.com

Biophytis Biotechnologie Cotation Refinancement Suspension Temporaire
REGULATED PRESS RELEASE

published on 01/06/2025 at 08:30, 1 year 7 months ago

Biophytis announces temporary suspension of the listing of its shares and share warrants prior to the completion of a refinancing transaction
Biophytis temporarily suspends listing of shares and share warrants prior to refinancing transaction. Trading to resume soon

Biophytis Shares Refinancing Listing Suspension

Accesswire

Published on 08/08/2026 at 00:00, 1 day 20 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 day 20 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 21 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 21 hours ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 21 hours ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/09/2026 at 15:05, 5 hours 3 minutes ago

GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/09/2026 at 00:01, 20 hours 7 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 1 day 3 hours ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 20 hours ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 2 days ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/07/2026 at 18:54, 2 days 1 hour ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 1 hour ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 1 hour ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 2 days 1 hour ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 2 days 2 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE